Bleakley Financial Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
+10,343
New +$1.19M 0.02% 596
2025
Q1
Sell
-4,359
Closed -$506K 1036
2024
Q4
$506K Buy
4,359
+96
+2% +$12.1K 0.02% 620
2024
Q3
$576K Buy
4,263
+152
+4% +$20.3K 0.02% 560
2024
Q2
$558K Buy
4,111
+69
+2% +$9.39K 0.02% 577
2024
Q1
$522K Buy
4,042
+90
+2% +$10.9K 0.02% 604
2023
Q4
$452K Buy
3,952
+150
+4% +$15K 0.01% 621
2023
Q3
$346K Sell
3,802
-1,260
-25% -$130K 0.01% 644
2023
Q2
$570K Buy
5,062
+1,060
+26% +$112K 0.02% 551
2023
Q1
$419K Sell
4,002
-289
-7% -$30.2K 0.01% 612
2022
Q4
$474K Buy
+4,291
New +$450K 0.02% 568

Other funds holding XYL

Bleakley Financial Group's XYL Position: Q2 2026 in Review

Bleakley Financial Group opened a new position in Xylem (XYL) in Q2 2026: 10,343 shares worth $1.22M. The stake represents 0.02% of the portfolio and ranks #596 among its holdings. This is a return to the name: Bleakley Financial Group previously reported a position in XYL as recently as Q4 2024.

Bleakley Financial Group first reported a position in XYL in Q4 2022 and has held it in 10 quarters since. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Bleakley Financial Group held 10,343 shares of Xylem worth $1.22M as of Q2 2026.
  • Xylem was a new Bleakley Financial Group position in Q2 2026.
  • Xylem made up 0.02% of Bleakley Financial Group's portfolio in Q2 2026, its #596 holding.
  • Bleakley Financial Group first reported a position in Xylem in Q4 2022 and has held it in 10 quarters since.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.